Mount Sinai researchers identify cells linked to ventricular chamber development

Katherine Davis | | Cardiovascular Business | Vascular & Endovascular

[[{"fid":"22342","view_mode":"default","type":"media","attributes":{"height":187,"width":244,"style":"float: right; margin-left: 12px; margin-right: 12px;","alt":"Cells - Cells","class":"media-element file-default"}}]]Researchers from Mount Sinai in New York found a population of cells that are linked to the development of heart ventricular chambers.

The study, published in Nature Communications, revealed in-depth information of the formation of heart chambers that could help researchers better understand the biology behind heart defects like congenital heart disease.

Researchers examined the role that Foxa2, a protein-coding gene, played in the development of the endoderm and ectoderm during embryogenesis. Investigators found a population of progenitor cells expressing Foxa2 during early development that formed cells in both the left and right ventricular chambers, but not the atria, showing that atrial-ventricular segregation happens before the morphological establishment of differentiated cardiac structures.

"In addition to informing our understanding of early heart development, we hope that these findings will also lead to new protocols for the generation of ventricular cardiomyocytes in cell culture that could potentially be used in therapeutic settings,” said Nicole Dubois, PhD, the lead author on the study and an assistant professor at the Icahn School of Medicine at Mount Sinai, in a statement.

Though researchers don’t understand much about Foxa2, the study provides a foundation for future work that can examine how the protein could be used to help treat heart conditions.

Katherine Davis,

Senior Writer

As a Senior Writer for TriMed Media Group, Katherine primarily focuses on producing news stories, Q&As and features for Cardiovascular Business. She reports on several facets of the cardiology industry, including emerging technology, new clinical trials and findings, and quality initiatives among providers. She is based out of TriMed's Chicago office and holds a bachelor's degree in journalism from Columbia College Chicago. Her work has appeared in Modern Healthcare, Crain's Chicago Business and The Detroit News. She joined TriMed in 2016.

Related Content

Angiographic catheters recalled due to safety risk
FDA clears blood clot removal system for treating pulmonary embolism
Tiny clot-busting robots could transform care for stroke and heart attack patients
New-look peripheral stent with expandable spikes receives FDA’s de novo classification
Terumo Interventional Systems launches dual-layer micromesh carotid stent after FDA approval
How anticoagulants may impact a patient’s risk of gastrointestinal bleeding after TAVR

Around the web

Health Exec
Tom Price: Medical residency slots need to expand to combat physician shortages

Tom Price, MD, former secretary of Health and Human Services (HHS), said one way to address the growing shortage of physicians is to expand medical resident positions, but these are tied to Medicare spending so alternative means may be needed.

Health Imaging
Tariffs will have a significant impact on the nuclear imaging supply chain in the US

"Domestic radiopharmaceutical suppliers, who receive isotopes from abroad, would be impacted by price changes and uncertainty caused by additional tariffs,” SNMMI President Cathy Cutler, PhD, wrote in a letter to the U.S. Department of Commerce this week.

Radiology Business
U.S. iodine contrast supply may not be subject to proposed 25% tariffs

If President Trump initiates a 25% tariff against pharmaceuticals imported from Ireland, it might impact the price for X-ray iodine contrast agents in the U.S. depending what rules are put in place.